While levels of plasma IFN-α, and IFN-β were below the levels of reliable detection, we found that the COVID-19 patients who were <60 years expressed significantly higher plasma IFN-γ levels when compared to levels in the plasma of healthy controls (Fig. 8a). The gene discussed is IFNA1; the disease is COVID-19.